Brief: Zimmer Biomet Q2 Adjusted EPS USD 2.07 Vs. IBES Estimate USD 2.01
BRIEF-Zimmer Biomet Q2 Adjusted EPS USD 2.07 Vs. IBES Estimate USD 2.01 Aug 05 (Reuters) - Zimmer Biomet Q2 sales USD 2,177 million vs. IBES estimate USD 2,134 million.
- Q2 EPS USD 1.03
- Q2 net income USD 198.3 million
- outlook FY adjusted EPS USD 8.47-8.59 vs. IBES estimate USD 8.48
- outlook FY revenue growth 3.9-4.9%
- Outlook FY revenue growth 3.9-4.9%
Recent news on Zimmer Biomet Holdings
See all newsMedical device makers slip in sympathy with J&J's MedTech miss
Brief: Zimmer Biomet And THINK Surgical Extend Exclusive Distribution Agreement
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Stryker taps insider Stiles to succeed industry veteran Lobo as CEO